{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:19:22Z","timestamp":1759335562077,"version":"3.41.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10072-025-08186-8","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:24:31Z","timestamp":1745540671000},"page":"4051-4055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stroke, idiopathic thrombocytopenic purpura and avatrombopag: two cases of coincident events"],"prefix":"10.1007","volume":"46","author":[{"given":"Bernat","family":"Boy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Iacoboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Valc\u00e1rcel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7953-3795","authenticated-orcid":false,"given":"Marc","family":"Rodrigo-Gisbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"8186_CR1","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s40265-021-01613-y","volume":"81","author":"A Markham","year":"2021","unstructured":"Markham A (2021) Avatrombopag: A review in thrombocytopenia. Drugs 81:1905\u20131913. https:\/\/doi.org\/10.1007\/s40265-021-01613-y","journal-title":"Drugs"},{"key":"8186_CR2","doi-asserted-by":"publisher","unstructured":"Bussel JB et al (Jun. 2014) A randomized trial of Avatrombopag, an investigational thrombopoietin- receptor agonist, in persistent and chronic immune thrombocytopenia. Blood 123:3887\u20133894. https:\/\/doi.org\/10.1182\/blood-2013-07-514398","DOI":"10.1182\/blood-2013-07-514398"},{"key":"8186_CR3","doi-asserted-by":"publisher","unstructured":"Jurczak W et al (Nov. 2018) Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia Br J Haematol 183(3):479\u2013490.https:\/\/doi.org\/10.1111\/bjh.15573","DOI":"10.1111\/bjh.15573"},{"key":"8186_CR4","doi-asserted-by":"publisher","unstructured":"Kuter DJ (May. 1 2022) The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag. Churchill Livingstonehttps:\/\/doi.org\/10.1016\/j.blre.2021.100909","DOI":"10.1016\/j.blre.2021.100909"},{"key":"8186_CR5","doi-asserted-by":"publisher","unstructured":"Rodeghiero F (Jan. 2016) Is ITP a thrombophilic disorder? Am J Hematol 91(1):39\u201345. https:\/\/doi.org\/10.1002\/ajh.24234","DOI":"10.1002\/ajh.24234"},{"key":"8186_CR6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.212845","author":"W Ghanima","year":"2019","unstructured":"Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB (2019) Thrombopoietin receptor agonists: ten years later. Ferrata Storti Foundation. https:\/\/doi.org\/10.3324\/haematol.2018.212845","journal-title":"Ferrata Storti Foundation"},{"key":"8186_CR7","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3324\/haematol.2009.018390","volume":"95","author":"A Sarpatwari","year":"2010","unstructured":"Sarpatwari A et al (2010) Thromboembolic events among adult patients with primary immune thrombocytopenia in the united Kingdom general practice research database. Haematologica 95:1167\u20131175. https:\/\/doi.org\/10.3324\/haematol.2009.018390","journal-title":"Haematologica"},{"key":"8186_CR8","doi-asserted-by":"publisher","unstructured":"Abdelsamia M, Farid S, Dean S, Cataland SR (Sep. 2023) Thrombotic complications in immune thrombocytopenia patients treated with avatrombopaghttps:\/\/doi.org\/10.3390\/hematolrep15030054","DOI":"10.3390\/hematolrep15030054"},{"key":"8186_CR9","doi-asserted-by":"publisher","unstructured":"Piatek CI, Jamieson B, Vredenburg M (Nov. 2020) Characterization of thromboembolic events occurring during the avatrombopag immune thrombocytopenia (ITP) clinical development program, Blood 136(Suppl 1):39. https:\/\/doi.org\/10.1182\/blood-2020-141273","DOI":"10.1182\/blood-2020-141273"},{"key":"8186_CR10","doi-asserted-by":"publisher","unstructured":"Frol S, Pretnar Oblak J, \u0160abovi\u010d M, Kermer P, Sever M (Sep. 2023) Treatment of acute ischaemic stroke and concomitant multiple arterial splanchnic thromboses in a patient with immune thrombocytopenia on thrombopoietin agonist: a case report. Neurol Int 15(3):1191\u20131199. https:\/\/doi.org\/10.3390\/neurolint15030074","DOI":"10.3390\/neurolint15030074"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08186-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08186-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08186-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:27:55Z","timestamp":1752643675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08186-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["8186"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08186-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Authors report no conflicts of interest. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}